For certain thyroid lesions, the shift is on

“Way overdue” is how many see the nomenclature revision for noninvasive encapsulated follicular variant of papillary thyroid carcinoma, says Yuri Nikiforov, MD, PhD, vice chair for molecular pathology and division director of molecular and genomic pathology, University of Pittsburgh Medical Center.

Read the full story »

From left: Dr. Raja Seethala, Dr. Sally Carty,
and Dr. Nikiforov

Laboratory 2.0: Changing the conversation

TriCore Reference Laboratories CEO Khosrow Shotorbani, MT(ASCP), put the matter succinctly to a group of laboratory leaders and other health care experts who met in Santa Fe, NM, this spring to tackle the conundrum of how to move from volume to value. “The question is,” Shotorbani said, “how do we survive in the future? If there is no margin, there is no mission.”

Read the full story »

Khosrow Shotorbani

Making the best of PD-L1 IHC testing

When Keith Kerr, MB ChB, describes the ideal biomarker, he isn’t hesitant about what pathologists and clinicians need. “Ideally, the biomarker would always be correct. It would be easy and practical to measure. It would either be present or absent, with no gray zone or doubt. The biomarker itself would be a stable and functionally unique factor related to the system being studied. And it would, of course, be 100 percent predictive.”

Read the full story »

Dr. Keith Kerr

Poisoning, overdose: Better technology, workflow improve patient odds

Some 2.3 million toxic exposures are reported annually and they may involve thousands of different agents—frequently more than one for an individual patient, says Kara Lynch, PhD, associate chief of the clinical chemistry and toxicology laboratory at Zuckerberg San Francisco General Hospital and associate professor at UCSF. “Half of these agents are pharmaceutical drugs, and as laboratories we can actually look for these with published methods, using mass spectrometry,” says Dr. Lynch.

Read the full story »

Dr. Kara Lynch

This Month’s Issue

Read, save, and print articles from the current issue

Articles

Chronological index
2013–2016

Product Guides

Compare all instruments
and software systems

Departments

Chronological index
2013–2015

Marketplace

New pathology lab products and industry news

Magazine Issue Archive

» 2013–2016 article index
»
2000–2012 article index

CAP TODAY Hosted Webinars

» Assessing the clinical genome: thoughts and lessons for improving diagnostic tests
»
All on-demand webinars

Product Guides

» Compare products side-by-side
»
Download product guide PDFs

Quick Links

» Subscribe or renew CAP TODAY
»
Search for jobs / Post open positions

July 2016 Issue Articles

Click on the article title to read, save,
or print as a PDF

» For certain thyroid lesions, the shift is on
» Laboratory 2.0: Changing the conversation
» Making the best of PD-L1 IHC testing
» All July 2016 articles

CAP TODAY Recommends

IHC testing’s impact on skin cancer

A free webinar sponsored by Sigma-Aldrich will review the utility of immunohistochemical testing with markers such as S-100, SOX-10, Ber-Ep4, and HHV-8 in accurately diagnosing skin cancer and improving survival rates for patients with the disease. Register.

Managing molecular information in the lab

As molecular technology and personalized medicine increasingly becomes the default position for clinical diagnostics laboratories, these modalities place significant demands on laboratory information systems. That is where molecular information management systems come into the picture. Download white paper.

The CPOE Lab Test: Utilization Opportunity

This editorial is brought to you through Roche’s Lab Leaders initiative.

The future of the lab in health care

CAP TODAY publisher Bob McGonnagle gathered with Orchard Software executives to discuss what lies ahead for laboratories.

» More CAP TODAY Recommends